Skip to main content

Table 2 Adverse effects

From: Meta-analysis of effect of vernakalant on conversion of atrial fibrillation

Study name T/C Adverse events
   Type T/C
Camm 2011 [11] 116/116 Monomorphic nonsustained 1/0
   ventricular tachycardia  
   Cardiac arrest 0/1
Pratt 2010 [7] 118/121 Ventricular tachycardia 16/13
   Ventricular fibrillation 1/0
   Bradycardia 8/0
   Hypotension 7/2
Roy 2004 [12] 36/20 Cardiac disorders 7/7
Roy 2008 [8] 221/115 Nonsustained ventricular tachycardia 14/17
   Bradycardia 1/0
   Hypotension 14/4
   Ventricular bigeminy 1/0
   Uncorrected QT > 550 ms 1/1
Stiell 2010 [13] 229/61 Any ventricular arrhythmia events 20/10
   Ventricular tachycardia 18/9
   Ventricular extrasystoles 2/1
   Bradycardia 21/7
   Hypotension 20/7